1. Home
  2. KLTR vs PHAT Comparison

KLTR vs PHAT Comparison

Compare KLTR & PHAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KLTR
  • PHAT
  • Stock Information
  • Founded
  • KLTR 2006
  • PHAT 2018
  • Country
  • KLTR United States
  • PHAT United States
  • Employees
  • KLTR N/A
  • PHAT N/A
  • Industry
  • KLTR EDP Services
  • PHAT Biotechnology: Pharmaceutical Preparations
  • Sector
  • KLTR Technology
  • PHAT Health Care
  • Exchange
  • KLTR Nasdaq
  • PHAT Nasdaq
  • Market Cap
  • KLTR 389.2M
  • PHAT 465.0M
  • IPO Year
  • KLTR 2021
  • PHAT 2019
  • Fundamental
  • Price
  • KLTR $2.28
  • PHAT $6.96
  • Analyst Decision
  • KLTR Buy
  • PHAT Strong Buy
  • Analyst Count
  • KLTR 2
  • PHAT 4
  • Target Price
  • KLTR $2.25
  • PHAT $23.00
  • AVG Volume (30 Days)
  • KLTR 729.0K
  • PHAT 971.9K
  • Earning Date
  • KLTR 02-20-2025
  • PHAT 03-06-2025
  • Dividend Yield
  • KLTR N/A
  • PHAT N/A
  • EPS Growth
  • KLTR N/A
  • PHAT N/A
  • EPS
  • KLTR N/A
  • PHAT N/A
  • Revenue
  • KLTR $177,586,000.00
  • PHAT $26,270,000.00
  • Revenue This Year
  • KLTR $3.34
  • PHAT $7,622.43
  • Revenue Next Year
  • KLTR $1.88
  • PHAT $236.87
  • P/E Ratio
  • KLTR N/A
  • PHAT N/A
  • Revenue Growth
  • KLTR 1.62
  • PHAT N/A
  • 52 Week Low
  • KLTR $0.76
  • PHAT $6.07
  • 52 Week High
  • KLTR $2.82
  • PHAT $19.71
  • Technical
  • Relative Strength Index (RSI)
  • KLTR 51.45
  • PHAT 37.02
  • Support Level
  • KLTR $1.93
  • PHAT $6.36
  • Resistance Level
  • KLTR $2.82
  • PHAT $7.20
  • Average True Range (ATR)
  • KLTR 0.20
  • PHAT 0.48
  • MACD
  • KLTR -0.02
  • PHAT 0.08
  • Stochastic Oscillator
  • KLTR 39.33
  • PHAT 30.48

About KLTR Kaltura Inc.

Kaltura Inc provides live and on-demand video SaaS solutions to thousands of organizations around the world, engaging hundreds of millions of viewers at home, at work, and at school. It also offers specialized industry solutions, including Learning Management System Video, Lecture Capture, and Virtual Classroom for educational institutions, as well as a TV Solution for media and telecom companies. It operates in two reporting segments which are Enterprise, Education, and Technology, and Media and Telecom. The majority of the revenue is derived from Enterprise, Education & Technology. The majority of the revenue is earned from the United States.

About PHAT Phathom Pharmaceuticals Inc.

Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection.

Share on Social Networks: